Compare CYRX & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | NEWT |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.6M | 395.5M |
| IPO Year | 2008 | N/A |
| Metric | CYRX | NEWT |
|---|---|---|
| Price | $8.00 | $11.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | $12.94 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 382.2K | 160.4K |
| Earning Date | 06-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.45% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $9.71 | N/A |
| Revenue Next Year | $9.56 | $12.45 |
| P/E Ratio | ★ $5.59 | $5.99 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.63 | $9.12 |
| 52 Week High | $11.45 | $14.91 |
| Indicator | CYRX | NEWT |
|---|---|---|
| Relative Strength Index (RSI) | 41.10 | 38.22 |
| Support Level | $6.57 | $11.40 |
| Resistance Level | $9.32 | $12.41 |
| Average True Range (ATR) | 0.45 | 0.44 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 22.57 | 23.10 |
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.